Skip Navigation


European Heart Journal Advance Access originally published online on May 18, 2005
European Heart Journal 2005 26(11):1115-1140; doi:10.1093/eurheartj/ehi204
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME/CE:
Take the course for this article:
ESC Guidelines on Chronic Heart Failu...
Right arrow All Versions of this Article:
26/11/1115    most recent
ehi204v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Remme, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Remme, W. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)

The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology

Authors/Task Force Members, Karl Swedberg, Chairperson, Göteborg (Sweden)* Writing Committee:, John Cleland, Hull (UK), Henry Dargie, Glasgow (UK), Helmut Drexler, Hannover (Germany), Ferenc Follath, Zurich (Switzerland), Michel Komajda, Paris (France), Luigi Tavazzi, Pavia (Italy), Otto A. Smiseth, Oslo (Norway) Other Contributors, Antonello Gavazzi, Bergamo (Italy), Axel Haverich, Hannover (Germany), Arno Hoes, Utrecht (The Netherlands), Tiny Jaarsma, Gronigen (The Netherlands), Jerzy Korewicki, Warsaw (Poland), Samuel Lévy, Marseille (France), Cecilia Linde, Stockholm (Sweden), José-Luis Lopez-Sendon, Madrid (Spain), Markku S. Nieminen, Helsinki (Finland), Luc Piérard, Liège (Belgium), Willem J. Remme, Rhoon (The Netherlands)

* Corresponding author. Chairperson: Karl Swedberg, Sahlgrenska Academy at the Göteborg University, Department of Medicine, Sahlgrenska University Hospital Östra, SE-416 85 Göteborg, Sweden. Tel.: +46 31 3434078; fax: +46 31 258933. E-mail address: karl.swedberg@hjl.gu.se

ESC Committee for Practice Guidelines (CPG), Silvia G. Priori (Chairperson) (Italy), Jean-Jacques Blanc (France), Andrzej Budaj (Poland), John Camm (UK), Veronica Dean (France), Jaap Deckers (The Netherlands), Kenneth Dickstein (Norway), John Lekakis (Greece), Keith McGregor (France), Marco Metra (Italy), João Morais (Portugal), Ady Osterspey (Germany), Juan Tamargo (Spain), José Luis Zamorano (Spain)
Document Reviewers, Marco Metra (CPG Review Coordinator) (Italy), Michael Böhm (Germany), Alain Cohen-Solal (France), Martin Cowie (UK), Ulf Dahlström (Sweden), Kenneth Dickstein (Norway), Gerasimos S. Filippatos (Greece), Edoardo Gronda (Italy), Richard Hobbs (UK), John K. Kjekshus (Norway), John McMurray (UK), Lars Rydén (Sweden), Gianfranco Sinagra (Italy), Juan Tamargo (Spain), Michal Tendera (Poland), Dirk van Veldhuisen (The Netherlands), Faiez Zannad (France)

The first 150 words of the full text of this article appear below.

Preamble

Guidelines and Expert Consensus Documents aim to present all the relevant evidence on a particular issue in order to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic procedure. They should be helpful in everyday clinical decision-making.

A great number of Guidelines and Expert Consensus Documents have been issued in recent years by the European Society of Cardiology (ESC) and by different organizations and other related societies. This profusion can put at stake the authority and validity of guidelines, which can only be guaranteed if they have been developed by an unquestionable decision-making process. This is one of the reasons why the ESC and others have issued recommendations for formulating and issuing Guidelines and Expert Consensus Documents.

In spite of the fact that standards for issuing good quality Guidelines and Expert Consensus Documents are well defined, recent surveys of Guidelines and Expert Consensus Documents published . . . [Full Text of this Article]

Diagnosis of chronic heart failure

Introduction

Methodology
Epidemiology

Descriptive terms in heart failure

Acute vs. chronic heart failure
Systolic vs. diastolic heart failure
Other descriptive terms in heart failure
Definition of chronic heart failure
Aspects of the pathophysiology of the symptoms of heart failure relevant to diagnosis

Possible methods for the diagnosis of heart failure in clinical practice

Symptoms and signs in the diagnosis of heart failure
Symptoms and the severity of heart failure
Electrocardiogram
The chest X-ray
Haematology and biochemistry
Natriuretic peptides
Echocardiography
Assessment of LV diastolic function
Diagnostic criteria of diastolic dysfunction
Additional non-invasive tests to be considered
Cardiac magnetic resonance imaging (CMR)
Pulmonary function
Exercise testing
Invasive investigation
Cardiac catheterization
Tests of neuroendocrine evaluations other than natriuretic peptides
Holter electrocardiography: ambulatory ECG and long-time ECG recording (LTER)
Requirements for the diagnosis of heart failure in clinical practice
Prognostication
Treatment of heart failure

Aims of treatment in heart failure

Prevention of heart failure

Management of chronic heart failure

Non-pharmacological management

General advice and measures
Educating patients and family
Weight monitoring
Dietary measures
Sodium
Fluids
Alcohol
Obesity
Abnormal weight loss
Smoking
Travelling
Sexual activity
Advice on immunizations
Drug counselling
Drugs to avoid or beware
Rest, exercise, and exercise training
Rest
Exercise
Pharmacological therapy

Angiotensin-converting enzyme inhibitors
ACE-inhibitors in asymptomatic left ventricular dysfunction
ACE-inhibitors in symptomatic heart failure
Diuretics
Loop diuretics, thiazides, and metolazone
Potassium-sparing diuretics
Beta-adrenoceptor antagonists
Initiation of therapy
Aldosterone receptor antagonists
Angiotensin II receptor blockers
Dosing
Cardiac glycosides
Digoxin
Vasodilator agents in chronic heart failure
Hydralazine-isosorbide dinitrate
Nitrates
Alpha-adrenergic blocking drugs
Calcium antagonists
Nesiritide
Positive inotropic therapy
Anti-thrombotic agents
Anti-arrhythmics
Class I anti-arrhythmics
Class II anti-arrhythmics
Class III anti-arrhythmics
Oxygen therapy
Surgery and devices

Revascularization procedures, mitral valve surgery, and ventricular restoration
Revascularization
Mitral valve surgery
Left ventricular restoration
LV aneurysmectomy
Cardiomyoplasty
Partial left ventriculectomy (Batista operation)
External ventricular restoration
Pacemakers
Implantable cardioverter defibrillators
Heart replacement therapies: heart transplantation, ventricular assist devices, and artificial heart
Heart transplantation
Ventricular assist devices and artificial heart
Ultrafiltration
Choice and timing of pharmacological therapy
Asymptomatic left ventricular systolic dysfunction
Symptomatic left ventricular systolic dysfunction: heart failure NYHA class II (Figure 4)
Without signs of fluid retention
With signs of fluid retention
Worsening heart failure (Figure 3)
End-stage heart failure (patients who persist in NYHA IV despite optimal treatment and proper diagnosis (Figure 4)
Management of heart failure with preserved left ventricular ejection fraction
Pharmacological therapy of heart failure with PLVEF or diastolic dysfunction
Heart failure treatment in the elderly

ACE-inhibitors and ARBs
Diuretic therapy
Beta-blockers
Cardiac glycosides
Vasodilator agents
Arrhythmias
Ventricular arrhythmias
Atrial fibrillation
Symptomatic systolic left ventricular dysfunction and concomitant angina or hypertension

Care and follow-up


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EuropaceHome page
A. M. Ferreira, P. Adragao, D. M. Cavaco, R. Candeias, F. B. Morgado, K. R. Santos, E. Santos, and J. A. Silva
Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation
Europace, July 1, 2008; 10(7): 809 - 815.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
E. Mandysova, T. Mraz, M. Taborsky, and P. Niederle
Reproducibility of tissue Doppler parameters of asynchrony in patients with advanced LV dysfunction
Eur J Echocardiogr, July 1, 2008; 9(4): 509 - 515.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
E. Donal, C. De Place, G. Kervio, F. Bauer, R. Gervais, C. Leclercq, P. Mabo, and J.-C. Daubert
Mitral regurgitation in dilated cardiomyopathy: value of both regional left ventricular contractility and dyssynchrony
Eur J Echocardiogr, June 26, 2008; (2008) jen188v1.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
N. Suskin, A. Pipe, and P. Prior
Smokers paradox or not in heart failure. Just quit
Eur. Heart J., June 12, 2008; (2008) ehn275v1.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A. Ciszewski, Z. T. Bilinska, L. B. Brydak, C. Kepka, M. Kruk, M. Romanowska, E. Ksiezycka, J. Przyluski, W. Piotrowski, R. Maczynska, et al.
Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study
Eur. Heart J., June 1, 2008; 29(11): 1350 - 1358.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. S. Chung, A. R. Leon, L. Tavazzi, J.-P. Sun, P. Nihoyannopoulos, J. Merlino, W. T. Abraham, S. Ghio, C. Leclercq, J. J. Bax, et al.
Results of the Predictors of Response to CRT (PROSPECT) Trial
Circulation, May 20, 2008; 117(20): 2608 - 2616.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. C. Fonarow, W. T. Abraham, N. M. Albert, W. G. Stough, M. Gheorghiade, B. H. Greenberg, C. M. O'Connor, E. Nunez, C. W. Yancy, and J. B. Young
A smoker's paradox in patients hospitalized for heart failure: findings from OPTIMIZE-HF
Eur. Heart J., May 15, 2008; (2008) ehn210v1.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
H. J. Verberne, L. M. Brewster, G. A. Somsen, and B. L.F. van Eck-Smit
Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review
Eur. Heart J., May 1, 2008; 29(9): 1147 - 1159.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Hammerer-Lercher, B. Halfinger, B. Sarg, J. Mair, B. Puschendorf, A. Griesmacher, N. A. Guzman, and H. H. Lindner
Analysis of Circulating Forms of proBNP and NT-proBNP in Patients with Severe Heart Failure
Clin. Chem., May 1, 2008; 54(5): 858 - 865.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Westermann, M. Kasner, P. Steendijk, F. Spillmann, A. Riad, K. Weitmann, W. Hoffmann, W. Poller, M. Pauschinger, H.-P. Schultheiss, et al.
Role of Left Ventricular Stiffness in Heart Failure With Normal Ejection Fraction
Circulation, April 22, 2008; 117(16): 2051 - 2060.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. J. Anderson, C. Miyazaki, G. R. Sutherland, and J. K. Oh
Patient Selection and Echocardiographic Assessment of Dyssynchrony in Cardiac Resynchronization Therapy
Circulation, April 15, 2008; 117(15): 2009 - 2023.
[Full Text] [PDF]


Home page
Eur Heart JHome page
I. Squire
Assessing prognosis in heart failure: you can see a lot if you look, but more if you look again ... ... ...
Eur. Heart J., April 2, 2008; 29(8): 959 - 960.
[Full Text] [PDF]


Home page
Eur Heart JHome page
I. Garcia-Bolao, B. Lopez, A. Macias, J. J. Gavira, P. Azcarate, and J. Diez
Impact of collagen type I turnover on the long-term response to cardiac resynchronization therapy
Eur. Heart J., April 1, 2008; 29(7): 898 - 906.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Torabi, J. G.F. Cleland, N. K. Khan, P. H. Loh, A. L. Clark, F. Alamgir, J. L. Caplin, A. S. Rigby, and K. Goode
The timing of development and subsequent clinical course of heart failure after a myocardial infarction
Eur. Heart J., April 1, 2008; 29(7): 859 - 870.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
H. P. Brunner-La Rocca
Do we understand why the heart fails?
Eur. Heart J., March 2, 2008; 29(6): 698 - 700.
[Full Text] [PDF]


Home page
Eur Heart JHome page
J. Abdulla, L. Kober, S. Z. Abildstrom, E. Christensen, W. P. T. James, and C. Torp-Pedersen
Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries
Eur. Heart J., March 1, 2008; 29(5): 594 - 601.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Quesada, G. Botto, A. Erdogan, M. Kozak, P. Lercher, J. C. Nielsen, O. Piot, R. Ricci, C. Weiss, D. Becker, et al.
Managed ventricular pacing vs. conventional dual-chamber pacing for elective replacements: the PreFER MVP study: clinical background, rationale, and design
Europace, March 1, 2008; 10(3): 321 - 326.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M J Lenzen, A Rosengren, W J M S. op Reimer, F Follath, E Boersma, M L Simoons, J G F Cleland, and M Komajda
Management of patients with heart failure in clinical practice: differences between men and women
Heart, March 1, 2008; 94(3): e10 - e10.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J G F Cleland, N Freemantle, J-C Daubert, W D Toff, F Leisch, and L Tavazzi
Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF study
Heart, March 1, 2008; 94(3): 278 - 283.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
J.-M. Tartiere, D. Logeart, L. Tartiere-Kesri, and A. Cohen-Solal
Colour tissue Doppler underestimates myocardial velocity as compared to spectral tissue Doppler: Poor reliability between both methods
Eur J Echocardiogr, March 1, 2008; 9(2): 268 - 272.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
T. Jaarsma, M. H. L. van der Wal, I. Lesman-Leegte, M.-L. Luttik, J. Hogenhuis, N. J. Veeger, R. Sanderman, A. W. Hoes, W. H. van Gilst, D. J. A. Lok, et al.
Effect of Moderate or Intensive Disease Management Program on Outcome in Patients With Heart Failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH)
Arch Intern Med, February 11, 2008; 168(3): 316 - 324.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Marcassa, J. J. Bax, F. Bengel, B. Hesse, C. L. Petersen, E. Reyes, R. Underwood, and on behalf of the European Council of Nuclear Cardi
Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement
Eur. Heart J., February 2, 2008; 29(4): 557 - 563.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. B. Young, W. T. Abraham, R. C. Bourge, M. A. Konstam, and L. W. Stevenson
Task Force 8: Training in Heart Failure: Endorsed by the Heart Failure Society of America
J. Am. Coll. Cardiol., January 22, 2008; 51(3): 383 - 389.
[Full Text] [PDF]


Home page
Eur Respir JHome page
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Complex chronic comorbidities of COPD
Eur. Respir. J., January 1, 2008; 31(1): 204 - 212.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C. Leclercq
Upgrading from right ventricular pacing to biventricular pacing in pacemaker patients with chronic heart failure
Heart, January 1, 2008; 94(1): 102 - 107.
[Full Text] [PDF]


Home page
EuropaceHome page
M. Stockburger, S. Fateh-Moghadam, A. Nitardy, O. Celebi, A. Krebs, D. Habedank, and R. Dietz
Baseline Doppler parameters are useful predictors of chronic left ventricular reduction in size by cardiac resynchronization therapy
Europace, January 1, 2008; 10(1): 69 - 74.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. G. Camici, S. K. Prasad, and O. E. Rimoldi
Stunning, Hibernation, and Assessment of Myocardial Viability
Circulation, January 1, 2008; 117(1): 103 - 114.
[Full Text] [PDF]


Home page
Eur Heart JHome page
L. T. Cooper, K. L. Baughman, A. M. Feldman, A. Frustaci, M. Jessup, U. Kuhl, G. N. Levine, J. Narula, R. C. Starling, J. Towbin, et al.
The role of endomyocardial biopsy in the management of cardiovascular disease: A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology
Eur. Heart J., December 2, 2007; 28(24): 3076 - 3093.
[Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
F. Frassi, L. Gargani, S. Gligorova, Q. Ciampi, G. Mottola, and E. Picano
Clinical and echocardiographic determinants of ultrasound lung comets
Eur J Echocardiogr, December 1, 2007; 8(6): 474 - 479.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
G. Boriani, C. Linde, and R. Sutton
Celebrating 50 years of electrical therapies for the heart
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I1 - I2.
[Full Text] [PDF]


Home page
Eur Heart J SupplHome page
T. Rossenbacker, S. G. Priori, and D. P. Zipes
The fight against sudden cardiac death: consensus guidelines as a reference
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I50 - I58.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
L. Padeletti, P. Pieragnoli, V. Jentzen, and A. Schuchert
The comorbidity of atrial fibrillation and heart failure: a challenge for electrical therapies
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I81 - I86.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
C. Leclercq, G. B. Bleeker, C. Linde, E. Donal, J. J. Bax, M. J. Schalij, and C. Daubert
Cardiac resynchronization therapy: clinical results and evolution of candidate selection
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I94 - I106.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Jourdain, G. Jondeau, and Y. Juilliere
Reply
J. Am. Coll. Cardiol., November 20, 2007; 50(21): 2098 - 2099.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
U. C. Hoppe
Plasma Brain Natriuretic Peptide-Guided Therapy Not Yet Justified
J. Am. Coll. Cardiol., November 20, 2007; 50(21): 2097 - 2098.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. von Haehling, E. A. Jankowska, N. G. Morgenthaler, C. Vassanelli, L. Zanolla, P. Rozentryt, G. S. Filippatos, W. Doehner, F. Koehler, J. Papassotiriou, et al.
Comparison of Midregional Pro-Atrial Natriuretic Peptide With N-Terminal Pro-B-Type Natriuretic Peptide in Predicting Survival in Patients With Chronic Heart Failure
J. Am. Coll. Cardiol., November 13, 2007; 50(20): 1973 - 1980.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. T. Cooper, K. L. Baughman, A. M. Feldman, A. Frustaci, M. Jessup, U. Kuhl, G. N. Levine, J. Narula, R. C. Starling, J. Towbin, et al.
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology
J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1914 - 1931.
[Full Text] [PDF]


Home page
CirculationHome page
L. T. Cooper, K. L. Baughman, A. M. Feldman, A. Frustaci, M. Jessup, U. Kuhl, G. N. Levine, J. Narula, R. C. Starling, J. Towbin, et al.
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, the American College of Cardiology, and the European Society of Cardiology
Circulation, November 6, 2007; 116(19): 2216 - 2233.
[Full Text] [PDF]


Home page
BMJHome page
S. K H Lam and A. Owen
Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials
BMJ, November 3, 2007; 335(7626): 925 - 925.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
H.-R. Neuberger, C. Mewis, D. J. van Veldhuisen, U. Schotten, I. C. van Gelder, M. A. Allessie, and M. Bohm
Management of atrial fibrillation in patients with heart failure
Eur. Heart J., November 1, 2007; 28(21): 2568 - 2577.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
K. Khunti, M. Stone, S. Paul, J. Baines, L. Gisborne, A. Farooqi, X. Luan, and I. Squire
Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial
Heart, November 1, 2007; 93(11): 1398 - 1405.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Sandek, J. Bauditz, A. Swidsinski, S. Buhner, J. Weber-Eibel, S. von Haehling, W. Schroedl, T. Karhausen, W. Doehner, M. Rauchhaus, et al.
Altered Intestinal Function in Patients With Chronic Heart Failure
J. Am. Coll. Cardiol., October 16, 2007; 50(16): 1561 - 1569.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
W. J. Paulus, C. Tschope, J. E. Sanderson, C. Rusconi, F. A. Flachskampf, F. E. Rademakers, P. Marino, O. A. Smiseth, G. De Keulenaer, A. F. Leite-Moreira, et al.
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
Eur. Heart J., October 2, 2007; 28(20): 2539 - 2550.
[Abstract] [Full Text] [PDF]


Home page